Founded at the Abramson Cancer Center at the University of Pennsylvania

Lindsey Zinck, PhD, RN, OCN, NEA-BC

Chief Nursing Officer for the Abramson Cancer Center, Cancer Service Line

Lindsey Zinck, PhD, RN, OCN, NEA-BC is an Innovation Faculty member at the Penn Center for Cancer Care Innovation (PC3I) and the inaugural Chief Nursing Officer for the Abramson Cancer Center and Cancer Service Line (CSL) at Penn Medicine. In her role as CNO, Lindsey is responsible for advancing in a collaborative fashion oncology nursing practice in the CSL Shared Services Clinics and Penn Medicine infusion services. Lindsey will lead the coordination of nursing care throughout the patient journey, from diagnosis, to treatment, to post-acute care, to survivorship – ensuring seamless nursing care across all sites of service, including virtual care. Lindsey will continue to focus on key priorities in support of our clinical teams, providers and patients such as optimizing evidence-based practice, enhancing patient engagement and experience, and innovative operations in support of staff and provider efficiency.

 

Prior to becoming CNO, Lindsey served as the Associate Chief Administrative Officer for the CSL since 2019, leading innovations in oncology care delivery and spearheading the CSL and Infusion Services clinical response to COVID. Lindsey joined Penn Medicine more than 10 years ago and has been a regional leader of infusion services for Penn Medicine. Lindsey has been an integral partner with the Penn Center for Cancer Care Innovation and has been an influential leader nationally in her work with the National Comprehensive Cancer Network and the Oncology Nursing Society.

 

Lindsey earned her Bachelor of Science in nursing from Villanova and her Master of Science in nursing and healthcare administration from Penn. She recently earned her PhD in Nursing Science at The Catholic University of America in DC. The focus of her dissertation study (Principal Investigator: Justin Bekelman) was examining patient satisfaction and quality of life between patients receiving Cancer Care at Home in comparison to the usual care in the Infusion Suites.

Related Publications